Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence.
Zhang C, Kallakury BV, Ross JS, Mewani RR, Sheehan CE, Sakabe I, Luta G, Kumar D, Yadavalli S, Starr J, Sreenath TL, Srivastava S, Pollard HB, Eidelman O, Srivastava M, Kasid UN. Zhang C, et al. Among authors: srivastava s, srivastava m. Int J Cancer. 2013 Jul;133(1):31-42. doi: 10.1002/ijc.27996. Epub 2013 Jan 10. Int J Cancer. 2013. PMID: 23280553 Free PMC article.
Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Sterbis JR, Gao C, Furusato B, Chen Y, Shaheduzzaman S, Ravindranath L, Osborn DJ, Rosner IL, Dobi A, McLeod DG, Sesterhenn IA, Srivastava S, Cullen J, Petrovics G. Sterbis JR, et al. Among authors: srivastava s. Clin Cancer Res. 2008 Feb 1;14(3):758-63. doi: 10.1158/1078-0432.CCR-07-1356. Clin Cancer Res. 2008. PMID: 18245536
Delineation of TMPRSS2-ERG splice variants in prostate cancer.
Hu Y, Dobi A, Sreenath T, Cook C, Tadase AY, Ravindranath L, Cullen J, Furusato B, Chen Y, Thangapazham RL, Mohamed A, Sun C, Sesterhenn IA, McLeod DG, Petrovics G, Srivastava S. Hu Y, et al. Among authors: srivastava s. Clin Cancer Res. 2008 Aug 1;14(15):4719-25. doi: 10.1158/1078-0432.CCR-08-0531. Clin Cancer Res. 2008. PMID: 18676740
ERG oncogene modulates prostaglandin signaling in prostate cancer cells.
Mohamed AA, Tan SH, Sun C, Shaheduzzaman S, Hu Y, Petrovics G, Chen Y, Sesterhenn IA, Li H, Sreenath T, McLeod DG, Dobi A, Srivastava S. Mohamed AA, et al. Among authors: srivastava s. Cancer Biol Ther. 2011 Feb 15;11(4):410-7. doi: 10.4161/cbt.11.4.14180. Epub 2011 Feb 15. Cancer Biol Ther. 2011. PMID: 21178489 Free PMC article.
Evaluation of ERG responsive proteome in prostate cancer.
Tan SH, Furusato B, Fang X, He F, Mohamed AA, Griner NB, Sood K, Saxena S, Katta S, Young D, Chen Y, Sreenath T, Petrovics G, Dobi A, McLeod DG, Sesterhenn IA, Saxena S, Srivastava S. Tan SH, et al. Among authors: srivastava s. Prostate. 2014 Jan;74(1):70-89. doi: 10.1002/pros.22731. Epub 2013 Sep 21. Prostate. 2014. PMID: 24115221 Free PMC article.
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
Rastogi A, Tan SH, Mohamed AA, Chen Y, Hu Y, Petrovics G, Sreenath T, Kagan J, Srivastava S, McLeod DG, Sesterhenn IA, Srivastava S, Dobi A, Srinivasan A. Rastogi A, et al. Among authors: srivastava s. Genes Cancer. 2014 Jul;5(7-8):273-84. doi: 10.18632/genesandcancer.25. Genes Cancer. 2014. PMID: 25221645 Free PMC article.
ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.
Griner NB, Young D, Chaudhary P, Mohamed AA, Huang W, Chen Y, Sreenath T, Dobi A, Petrovics G, Vishwanatha JK, Sesterhenn IA, Srivastava S, Tan SH. Griner NB, et al. Among authors: srivastava s. Mol Cancer Res. 2015 Feb;13(2):368-79. doi: 10.1158/1541-7786.MCR-14-0275-T. Epub 2014 Oct 24. Mol Cancer Res. 2015. PMID: 25344575 Free PMC article.
6,155 results